Related Experiment Video
Updated: Sep 30, 2026

A BW Reporter System for Studying Receptor-Ligand Interactions
Published on: January 7, 2019
From orphan receptor to versatile regulator: Redefining LILRB3 as a context-dependent immune checkpoint and
Xinyu Zong1, Zhiqin Zhu2, Xionghan Zhang1
1Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Abstract:
The immune system maintains homeostasis through a delicate balance between activation and inhibition. While activating pattern recognition receptors (PRRs) are well-established initiators of innate immunity, the role of inhibitory PRRs (iPRRs) in providing negative regulation is an emerging paradigm. Among these, Leukocyte Immunoglobulin-Like Receptor Subfamily B Member 3 (LILRB3), a myeloid-specific receptor, has recently undergone a dramatic conceptual transformation. Once considered a minor "orphan" receptor, LILRB3 is increasingly recognized as a context-dependent immune checkpoint with diverse immunoregulatory functions. Breakthrough studies in recent years have revealed its role as a putative cell surface receptor for APOE4 in Alzheimer's disease, a supporter of leukemia development via a non-canonical TRAF2-cFLIP-NF-κB signaling axis in acute myeloid leukemia (AML), and a genetic risk factor for kidney transplant failure in African American recipients. This review synthesizes these recent advances to present a unified framework of LILRB3 biology. We comprehensively detail its polymorphic gene structure, multi-domain architecture, and complex regulatory mechanisms governing its cell-type-specific expression. We expand upon its diverse ligand repertoire, encompassing both HLA-I-dependent and independent molecules, and dissect its versatile signaling pathways, from canonical ITIM-SHP1/2-mediated inhibition to non-canonical, phosphatase-independent functions. A central theme is the context-dependent role of LILRB3 across diseases: it can be detrimental in cancer by fostering an immunosuppressive microenvironment or beneficial in maintaining tissue homeostasis. Finally, we critically evaluate the translational landscape, including antagonistic/agonistic antibodies, CAR-T therapies, and biomarker-driven strategies, while addressing key challenges like cross-reactivity with LILRA6. By positioning LILRB3 within the emerging iPRR framework, this review highlights its potential therapeutic relevance across immunology, neurology, and oncology, and outlines a roadmap for future research and precision targeting.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of the Unfolded Protein Response
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Negative Regulator Molecules
Regulation of Expression at Multiple Steps
TGF - β Signaling Pathway
